xmlui.dri2xhtml.structural.head-subtitle

Oral lipid-based nanoformulation of tafenoquine enhanced bioavailability and blood stage antimalarial efficacy and led to a reduction in human red blood cell loss in mice




Files in this item

This item appears in the following Collection(s)

Search Our NM-AIST IR


Browse NM-AIST IR

My NM-AIST IR Account

Statistics